Dr. Reddy's Laboratories Limited Share Price & Technical Analysis
DRREDDY · ₹1,307 (-0.86%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,307
-0.86%
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical pro…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-1% return in May, -3% avg return in past 3 year May month.
6% return in 2026, 14% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 8% | 0% | 3% | -1% | – | – | – | – | – | – | – | 6% |
| 25 | -12% | -7% | 2% | 3% | 6% | 3% | -1% | 0% | -3% | -2% | 5% | 1% | -5% |
| 24 | 6% | 5% | -5% | 0% | -7% | 8% | 5% | 3% | -4% | -6% | -6% | 14% | 15% |
| 23 | 2% | -1% | 7% | 6% | -8% | 14% | 9% | -1% | -1% | -4% | 7% | 0% | 32% |
| 22 | -12% | -6% | 6% | -4% | 6% | 1% | -7% | 3% | 3% | 3% | 1% | -6% | -13% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹1.06T
P/E ratio
18.72
52W high
₹1,380
52W low
₹1,148
Volume
20,02,378
Beta
0.29
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Dr. Reddy's Laboratories Limited share price today?
- Dr. Reddy's Laboratories Limited (DRREDDY) last traded around ₹1,307 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does DRREDDY have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DRREDDY. Download the app for real-time alerts.
- How can I analyze Dr. Reddy's Laboratories Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.